Jian-Sheng Gong
International Institute of Minnesota
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Jian-Sheng Gong.
Mechanisms of Ageing and Development | 2000
Masashi Tanaka; Jian-Sheng Gong; Jin Zhang; Yoshiji Yamada; Harm-Jan Borgeld; Kunio Yagi
Mitochondria are not only the major site of ATP production in cells but also an important source of reactive oxygen species (ROS) under certain pathological conditions. Because mitochondrial DNA (mtDNA) in the mitochondrial matrix is exposed to ROS that leak from the respiratory chain, this extranuclear genome is prone to mutations. Therefore, the mitochondrial genome is a rich source of single nucleotide polymorphisms (SNPs) and the functional significance of SNPs in the mitochondrial genome is comparable to that of SNPs in the entire nuclear genome. To demonstrate the contribution of mitochondrial SNPs to the susceptibility to adult-onset diseases, we analyzed the mtDNA from Japanese centenarians and identified a longevity-associated mitochondrial genotype, Mt5178A. Because this genotype was demonstrated to suppress the occurrence of mtDNA mutations in the oocytes, it also would seem to decelerate the accumulation of mtDNA mutations in the somatic cells with increasing age. This genotype is likely to confer resistance to adult-onset diseases by suppressing obesity and atherosclerosis.
Annals of the New York Academy of Sciences | 1996
Masashi Tanaka; Sergey A. Kovalenko; Jian-Sheng Gong; Harm‐Jan W. Borgeld; Kazumi Katsumata; Mika Hayakawa; Makoto Yoneda; Takayuki Ozawa
Accumulation of various mutations in the mitochondrial genome is proposed as an important contributor to aging and degenerative diseases. Extensive fragmentation of mtDNA was detected in association with increased 8-hydroxydeoxyguanosine content in the heart mitochondrial DNA (mtDNA) from a patient with premature aging and mitochondrial cardiomyopathy, who carried a mutation within the mitochondrial tRNA(Asp) gene. This result suggests that damage to mtDNA by hydroxyl radical and accumulation of deleted mtDNA can be accelerated by a specific mitochondrial genotype. Similarly, extensive fragmentation of mtDNA was also detected in cultured cells exposed to a high oxygen concentration atmosphere, implying that mtDNA is vulnerable to reactive oxygen species. To clarify the role of point mutations accumulated in mtDNA, we examined the sequence heterogeneity of mtDNA in the skeletal muscle of a MELAS patient who carried a mutation within the mitochondrial tRNA(leu)(UUR) gene. The analysis revealed that the frequency of mutant clones in the MELAS muscle was significantly higher than those in an age-matched control muscle and a control placenta. Some of these nucleotide substitutions were missense and nonsense mutations, which potentially have deleterious effects on the mitochondrial function. The frequency of nucleotide substitutions in the striatum of three patients with Parkinsons disease was also significantly higher than that in control tissues. We also observed increased protein modification by 4-hydroxy-2-nonenal, a lipid peroxidation by-product, in Parkinsons disease. These results suggests that a vicious cycle contributes to the progression of degenerative process. In this cycle, first a primary mitochondrial mutation(s) induces a mitochondrial respiratory defect, which increases the leakage of reactive oxygen species (ROS) from the respiratory chain. Then the ROS would trigger accumulation of secondary mtDNA mutations in postmitotic cells, leading to further aggravation of mitochondrial respiratory defects and increased production of ROS and lipid peroxides from mitochondria, and thus resulting in degeneration of cellular components.
Japanese Circulation Journal-english Edition | 2001
Fumio Terasaki; Masashi Tanaka; Keishiro Kawamura; Yumiko Kanzaki; Makoto Okabe; Tetsuya Hayashi; Hiroaki Shimomura; Takahide Ito; Michihiro Suwa; Jian-Sheng Gong; Jin Zhang; Yasushi Kitaura
This report describes a case of cardiomyopathy with a novel point mutation of mitochondrial DNA coding lysine tRNA in association with severe ultrastructural alterations of the mitochondria in the cardiomyocytes. Abnormalities of energy production and/or abnormal protein synthesis because of the mutation of mitochondrial DNA may have played an important role in the pathogenesis of this case, which showed severe cardiomyocyte degeneration and deterioration from hypertrophic cardiomyopathy to severe dilated cardiomyopathy.
Iubmb Life | 1998
Jin Zhang; Makoto Yoneda; Keiji Naruse; Harm‐Jan W. Borgeld; Jian-Sheng Gong; Shuichi Obata; Masashi Tanaka; Kunio Yagi
When cybrids with a point mutation, which locates in the tRNALeu(UUR) gene of mtDNA and causes a mitochondrial encephalomyopathy (MELAS syndrome), were exposed to a high concentration of oxygen (95%), the peroxide production markedly increased by 6 h of oxygen exposure, whereas the peroxide production was similar among the cybrids under a normal concentration of oxygen. The peroxide production by oxygen exposure was enhanced particularly in cybrids with high proportions of the mutant mtDNA and low respiratory capacities. The appearance of apoptotic cells by oxygen exposure was high in cybrids with the impaired respiratory function due to the mutation. An antioxidant NAC successfully suppressed both the peroxide production and apoptosis. These results imply that the peroxide production plays an important role in inducing apoptosis in cells carrying the mtDNA mutation causing encephalomyopathy.
The Lancet | 1998
Masashi Tanaka; Jian-Sheng Gong; Jin Zhang; Makoto Yoneda; Kunio Yagi
Journal of Biomedical Science | 2002
Masashi Tanaka; Harm-Jan Borgeld; Jin Zhang; Shin-ichi Muramatsu; Jian-Sheng Gong; Makoto Yoneda; Wakako Maruyama; Makoto Naoi; Ibi T; Ko Sahashi; Masayo Shamoto; Noriyuki Fuku; Miyuki Kurata; Yoshiji Yamada; Kumi Nishizawa; Yukihiro Akao; Nobuko Ohishi; Shigeaki Miyabayashi; Hiraku Umemoto; Tatsuo Muramatsu; Koichi Furukawa; Akihiko Kikuchi; Imaharu Nakano; Keiya Ozawa; Kunio Yagi
Atherosclerosis | 2004
Katsumasa Takagi; Yoshiji Yamada; Jian-Sheng Gong; Takahito Sone; Mitsuhiro Yokota; Masashi Tanaka
Diabetes Care | 2001
Hajime Matsunaga; Yasushi Tanaka; Masashi Tanaka; Jian-Sheng Gong; Jin Zhang; Takashi Nomiyama; Osamu Ogawa; Takeshi Ogihara; Yoshiji Yamada; Kunio Yagi; Ryuzo Kawamori
Diabetes Care | 2002
Yasuko Uchigata; Taisuke Okada; Jian-Sheng Gong; Yoshiji Yamada; Yasuhiko Iwamoto; Massashi Tanaka
Japanese Circulation Journal-english Edition | 2001
Fumio Terasaki; Masashi Tanaka; Keishiro Kawamura; Yumiko Kanzaki; Makoto Okabe; Tetsuya Hayashi; Hiroaki Shimomura; Takahide Ito; Michihiro Suwa; Jian-Sheng Gong; Jin Zhang; Yasushi Kitaura